Loading…

MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia

The MYB oncogene is a leucine zipper transcription factor essential for normal and malignant hematopoiesis. In T-cell acute lymphoblastic leukemia (T-ALL), elevated MYB levels can arise directly through T-cell receptor-mediated MYB translocations, genomic MYB duplications or enhanced TAL1 complex bi...

Full description

Saved in:
Bibliographic Details
Published in:Leukemia 2015-04, Vol.29 (4), p.798-806
Main Authors: Mets, E, Van der Meulen, J, Van Peer, G, Boice, M, Mestdagh, P, Van de Walle, I, Lammens, T, Goossens, S, De Moerloose, B, Benoit, Y, Van Roy, N, Clappier, E, Poppe, B, Vandesompele, J, Wendel, H-G, Taghon, T, Rondou, P, Soulier, J, Van Vlierberghe, P, Speleman, F
Format: Article
Language:English
Subjects:
RNA
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c602t-c6717f4c95c5852059085f7362b49383b98a52ea73b7faf6d4cb5bedf8e40af33
cites cdi_FETCH-LOGICAL-c602t-c6717f4c95c5852059085f7362b49383b98a52ea73b7faf6d4cb5bedf8e40af33
container_end_page 806
container_issue 4
container_start_page 798
container_title Leukemia
container_volume 29
creator Mets, E
Van der Meulen, J
Van Peer, G
Boice, M
Mestdagh, P
Van de Walle, I
Lammens, T
Goossens, S
De Moerloose, B
Benoit, Y
Van Roy, N
Clappier, E
Poppe, B
Vandesompele, J
Wendel, H-G
Taghon, T
Rondou, P
Soulier, J
Van Vlierberghe, P
Speleman, F
description The MYB oncogene is a leucine zipper transcription factor essential for normal and malignant hematopoiesis. In T-cell acute lymphoblastic leukemia (T-ALL), elevated MYB levels can arise directly through T-cell receptor-mediated MYB translocations, genomic MYB duplications or enhanced TAL1 complex binding at the MYB locus or indirectly through the TAL1/miR-223/FBXW7 regulatory axis. In this study, we used an unbiased MYB 3'untranslated region-microRNA (miRNA) library screen and identified 33 putative MYB-targeting miRNAs. Subsequently, transcriptome data from two independent T-ALL cohorts and different subsets of normal T-cells were used to select miRNAs with relevance in the context of normal and malignant T-cell transformation. Hereby, miR-193b-3p was identified as a novel bona fide tumor-suppressor miRNA that targets MYB during malignant T-cell transformation thereby offering an entry point for efficient MYB targeting-oriented therapies for human T-ALL.
doi_str_mv 10.1038/leu.2014.276
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4890642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A410904298</galeid><sourcerecordid>A410904298</sourcerecordid><originalsourceid>FETCH-LOGICAL-c602t-c6717f4c95c5852059085f7362b49383b98a52ea73b7faf6d4cb5bedf8e40af33</originalsourceid><addsrcrecordid>eNqFkl1rFDEUhgdR7LZ657UEBPHCWfOdzI2wFr-gVZB64VXIZM_sps4k4yQj7L9vlta6FVESkpA8eXNOzltVTwheEsz0qx7mJcWEL6mS96oF4UrWQghyv1pgrVUtG8qPquOULjHeH8qH1REVlBHF2aIaz72b4pdPq5o0rK3ZiKzLCdnSUZ6HOKE0j-MEKZVlu0PZThvIPmxQ3gI6__YGxeDiBgIgH9BF7aDvi8ScAfW7YdzGtrcpe4dKmN9h8PZR9aCzfYLHN_NJ9fXd24vTD_XZ5_cfT1dntZOY5jIqojruGuGEFhSLBmvRKSZpyxumWdtoKyhYxVrV2U6uuWtFC-tOA8e2Y-yken2tO87tAGsHIU-2N-PkBzvtTLTe3D0Jfms28afhusGS0yLw4kZgij9mSNkMPu3TswHinAyRmjHBCcUFffYHehnnKZT0DGWMSMJwI_5FEakoVlQp9Zva2B6MD10s0bn902bFCW4wp40u1PIvVGnr8scuBuh82b9z4fnBhS3YPm9T7OfsY0hmJQkueWhM_gceKr68Bot_Upqgu_1bgs3emaaU3OydaYozC_70sB638C8rsismxtqn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1672072777</pqid></control><display><type>article</type><title>MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia</title><source>Springer Link</source><creator>Mets, E ; Van der Meulen, J ; Van Peer, G ; Boice, M ; Mestdagh, P ; Van de Walle, I ; Lammens, T ; Goossens, S ; De Moerloose, B ; Benoit, Y ; Van Roy, N ; Clappier, E ; Poppe, B ; Vandesompele, J ; Wendel, H-G ; Taghon, T ; Rondou, P ; Soulier, J ; Van Vlierberghe, P ; Speleman, F</creator><creatorcontrib>Mets, E ; Van der Meulen, J ; Van Peer, G ; Boice, M ; Mestdagh, P ; Van de Walle, I ; Lammens, T ; Goossens, S ; De Moerloose, B ; Benoit, Y ; Van Roy, N ; Clappier, E ; Poppe, B ; Vandesompele, J ; Wendel, H-G ; Taghon, T ; Rondou, P ; Soulier, J ; Van Vlierberghe, P ; Speleman, F</creatorcontrib><description>The MYB oncogene is a leucine zipper transcription factor essential for normal and malignant hematopoiesis. In T-cell acute lymphoblastic leukemia (T-ALL), elevated MYB levels can arise directly through T-cell receptor-mediated MYB translocations, genomic MYB duplications or enhanced TAL1 complex binding at the MYB locus or indirectly through the TAL1/miR-223/FBXW7 regulatory axis. In this study, we used an unbiased MYB 3'untranslated region-microRNA (miRNA) library screen and identified 33 putative MYB-targeting miRNAs. Subsequently, transcriptome data from two independent T-ALL cohorts and different subsets of normal T-cells were used to select miRNAs with relevance in the context of normal and malignant T-cell transformation. Hereby, miR-193b-3p was identified as a novel bona fide tumor-suppressor miRNA that targets MYB during malignant T-cell transformation thereby offering an entry point for efficient MYB targeting-oriented therapies for human T-ALL.</description><identifier>ISSN: 0887-6924</identifier><identifier>EISSN: 1476-5551</identifier><identifier>DOI: 10.1038/leu.2014.276</identifier><identifier>PMID: 25231743</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>3' Untranslated Regions ; Acute lymphoblastic leukemia ; Acute lymphocytic leukemia ; Animals ; Basic Helix-Loop-Helix Transcription Factors - genetics ; Basic Helix-Loop-Helix Transcription Factors - metabolism ; Care and treatment ; Cdc4 protein ; Cell Cycle Proteins - genetics ; Cell Cycle Proteins - metabolism ; Cell Transformation, Neoplastic - genetics ; Cell Transformation, Neoplastic - metabolism ; Development and progression ; F-Box Proteins - genetics ; F-Box Proteins - metabolism ; F-Box-WD Repeat-Containing Protein 7 ; Gene expression ; Gene Expression Profiling ; Gene Expression Regulation, Leukemic ; Genetic aspects ; Genomic Library ; Health aspects ; Hematopoiesis ; Humans ; Innovations ; Leucine ; Leucine zipper proteins ; Leukemia ; Lymphatic leukemia ; Lymphocytes T ; Mice ; MicroRNA ; MicroRNAs ; MicroRNAs - genetics ; MicroRNAs - metabolism ; miRNA ; Molecular targeted therapy ; Oncogenes ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology ; Primary Cell Culture ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins - metabolism ; Proto-Oncogene Proteins c-myb - genetics ; Proto-Oncogene Proteins c-myb - metabolism ; Ribonucleic acid ; RNA ; Signal Transduction ; T cell receptors ; T-Cell Acute Lymphocytic Leukemia Protein 1 ; T-Lymphocytes - metabolism ; T-Lymphocytes - pathology ; Transcriptome ; Transformations ; Translocation ; Tumor suppressor genes ; Tumors ; Ubiquitin-Protein Ligases - genetics ; Ubiquitin-Protein Ligases - metabolism</subject><ispartof>Leukemia, 2015-04, Vol.29 (4), p.798-806</ispartof><rights>COPYRIGHT 2015 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Apr 2015</rights><rights>Macmillan Publishers Limited 2015.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c602t-c6717f4c95c5852059085f7362b49383b98a52ea73b7faf6d4cb5bedf8e40af33</citedby><cites>FETCH-LOGICAL-c602t-c6717f4c95c5852059085f7362b49383b98a52ea73b7faf6d4cb5bedf8e40af33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,786,790,891,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25231743$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mets, E</creatorcontrib><creatorcontrib>Van der Meulen, J</creatorcontrib><creatorcontrib>Van Peer, G</creatorcontrib><creatorcontrib>Boice, M</creatorcontrib><creatorcontrib>Mestdagh, P</creatorcontrib><creatorcontrib>Van de Walle, I</creatorcontrib><creatorcontrib>Lammens, T</creatorcontrib><creatorcontrib>Goossens, S</creatorcontrib><creatorcontrib>De Moerloose, B</creatorcontrib><creatorcontrib>Benoit, Y</creatorcontrib><creatorcontrib>Van Roy, N</creatorcontrib><creatorcontrib>Clappier, E</creatorcontrib><creatorcontrib>Poppe, B</creatorcontrib><creatorcontrib>Vandesompele, J</creatorcontrib><creatorcontrib>Wendel, H-G</creatorcontrib><creatorcontrib>Taghon, T</creatorcontrib><creatorcontrib>Rondou, P</creatorcontrib><creatorcontrib>Soulier, J</creatorcontrib><creatorcontrib>Van Vlierberghe, P</creatorcontrib><creatorcontrib>Speleman, F</creatorcontrib><title>MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia</title><title>Leukemia</title><addtitle>Leukemia</addtitle><description>The MYB oncogene is a leucine zipper transcription factor essential for normal and malignant hematopoiesis. In T-cell acute lymphoblastic leukemia (T-ALL), elevated MYB levels can arise directly through T-cell receptor-mediated MYB translocations, genomic MYB duplications or enhanced TAL1 complex binding at the MYB locus or indirectly through the TAL1/miR-223/FBXW7 regulatory axis. In this study, we used an unbiased MYB 3'untranslated region-microRNA (miRNA) library screen and identified 33 putative MYB-targeting miRNAs. Subsequently, transcriptome data from two independent T-ALL cohorts and different subsets of normal T-cells were used to select miRNAs with relevance in the context of normal and malignant T-cell transformation. Hereby, miR-193b-3p was identified as a novel bona fide tumor-suppressor miRNA that targets MYB during malignant T-cell transformation thereby offering an entry point for efficient MYB targeting-oriented therapies for human T-ALL.</description><subject>3' Untranslated Regions</subject><subject>Acute lymphoblastic leukemia</subject><subject>Acute lymphocytic leukemia</subject><subject>Animals</subject><subject>Basic Helix-Loop-Helix Transcription Factors - genetics</subject><subject>Basic Helix-Loop-Helix Transcription Factors - metabolism</subject><subject>Care and treatment</subject><subject>Cdc4 protein</subject><subject>Cell Cycle Proteins - genetics</subject><subject>Cell Cycle Proteins - metabolism</subject><subject>Cell Transformation, Neoplastic - genetics</subject><subject>Cell Transformation, Neoplastic - metabolism</subject><subject>Development and progression</subject><subject>F-Box Proteins - genetics</subject><subject>F-Box Proteins - metabolism</subject><subject>F-Box-WD Repeat-Containing Protein 7</subject><subject>Gene expression</subject><subject>Gene Expression Profiling</subject><subject>Gene Expression Regulation, Leukemic</subject><subject>Genetic aspects</subject><subject>Genomic Library</subject><subject>Health aspects</subject><subject>Hematopoiesis</subject><subject>Humans</subject><subject>Innovations</subject><subject>Leucine</subject><subject>Leucine zipper proteins</subject><subject>Leukemia</subject><subject>Lymphatic leukemia</subject><subject>Lymphocytes T</subject><subject>Mice</subject><subject>MicroRNA</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>miRNA</subject><subject>Molecular targeted therapy</subject><subject>Oncogenes</subject><subject>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics</subject><subject>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism</subject><subject>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology</subject><subject>Primary Cell Culture</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Proto-Oncogene Proteins c-myb - genetics</subject><subject>Proto-Oncogene Proteins c-myb - metabolism</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>Signal Transduction</subject><subject>T cell receptors</subject><subject>T-Cell Acute Lymphocytic Leukemia Protein 1</subject><subject>T-Lymphocytes - metabolism</subject><subject>T-Lymphocytes - pathology</subject><subject>Transcriptome</subject><subject>Transformations</subject><subject>Translocation</subject><subject>Tumor suppressor genes</subject><subject>Tumors</subject><subject>Ubiquitin-Protein Ligases - genetics</subject><subject>Ubiquitin-Protein Ligases - metabolism</subject><issn>0887-6924</issn><issn>1476-5551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqFkl1rFDEUhgdR7LZ657UEBPHCWfOdzI2wFr-gVZB64VXIZM_sps4k4yQj7L9vlta6FVESkpA8eXNOzltVTwheEsz0qx7mJcWEL6mS96oF4UrWQghyv1pgrVUtG8qPquOULjHeH8qH1REVlBHF2aIaz72b4pdPq5o0rK3ZiKzLCdnSUZ6HOKE0j-MEKZVlu0PZThvIPmxQ3gI6__YGxeDiBgIgH9BF7aDvi8ScAfW7YdzGtrcpe4dKmN9h8PZR9aCzfYLHN_NJ9fXd24vTD_XZ5_cfT1dntZOY5jIqojruGuGEFhSLBmvRKSZpyxumWdtoKyhYxVrV2U6uuWtFC-tOA8e2Y-yken2tO87tAGsHIU-2N-PkBzvtTLTe3D0Jfms28afhusGS0yLw4kZgij9mSNkMPu3TswHinAyRmjHBCcUFffYHehnnKZT0DGWMSMJwI_5FEakoVlQp9Zva2B6MD10s0bn902bFCW4wp40u1PIvVGnr8scuBuh82b9z4fnBhS3YPm9T7OfsY0hmJQkueWhM_gceKr68Bot_Upqgu_1bgs3emaaU3OydaYozC_70sB638C8rsismxtqn</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Mets, E</creator><creator>Van der Meulen, J</creator><creator>Van Peer, G</creator><creator>Boice, M</creator><creator>Mestdagh, P</creator><creator>Van de Walle, I</creator><creator>Lammens, T</creator><creator>Goossens, S</creator><creator>De Moerloose, B</creator><creator>Benoit, Y</creator><creator>Van Roy, N</creator><creator>Clappier, E</creator><creator>Poppe, B</creator><creator>Vandesompele, J</creator><creator>Wendel, H-G</creator><creator>Taghon, T</creator><creator>Rondou, P</creator><creator>Soulier, J</creator><creator>Van Vlierberghe, P</creator><creator>Speleman, F</creator><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20150401</creationdate><title>MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia</title><author>Mets, E ; Van der Meulen, J ; Van Peer, G ; Boice, M ; Mestdagh, P ; Van de Walle, I ; Lammens, T ; Goossens, S ; De Moerloose, B ; Benoit, Y ; Van Roy, N ; Clappier, E ; Poppe, B ; Vandesompele, J ; Wendel, H-G ; Taghon, T ; Rondou, P ; Soulier, J ; Van Vlierberghe, P ; Speleman, F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c602t-c6717f4c95c5852059085f7362b49383b98a52ea73b7faf6d4cb5bedf8e40af33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>3' Untranslated Regions</topic><topic>Acute lymphoblastic leukemia</topic><topic>Acute lymphocytic leukemia</topic><topic>Animals</topic><topic>Basic Helix-Loop-Helix Transcription Factors - genetics</topic><topic>Basic Helix-Loop-Helix Transcription Factors - metabolism</topic><topic>Care and treatment</topic><topic>Cdc4 protein</topic><topic>Cell Cycle Proteins - genetics</topic><topic>Cell Cycle Proteins - metabolism</topic><topic>Cell Transformation, Neoplastic - genetics</topic><topic>Cell Transformation, Neoplastic - metabolism</topic><topic>Development and progression</topic><topic>F-Box Proteins - genetics</topic><topic>F-Box Proteins - metabolism</topic><topic>F-Box-WD Repeat-Containing Protein 7</topic><topic>Gene expression</topic><topic>Gene Expression Profiling</topic><topic>Gene Expression Regulation, Leukemic</topic><topic>Genetic aspects</topic><topic>Genomic Library</topic><topic>Health aspects</topic><topic>Hematopoiesis</topic><topic>Humans</topic><topic>Innovations</topic><topic>Leucine</topic><topic>Leucine zipper proteins</topic><topic>Leukemia</topic><topic>Lymphatic leukemia</topic><topic>Lymphocytes T</topic><topic>Mice</topic><topic>MicroRNA</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>miRNA</topic><topic>Molecular targeted therapy</topic><topic>Oncogenes</topic><topic>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics</topic><topic>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism</topic><topic>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology</topic><topic>Primary Cell Culture</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Proto-Oncogene Proteins c-myb - genetics</topic><topic>Proto-Oncogene Proteins c-myb - metabolism</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>Signal Transduction</topic><topic>T cell receptors</topic><topic>T-Cell Acute Lymphocytic Leukemia Protein 1</topic><topic>T-Lymphocytes - metabolism</topic><topic>T-Lymphocytes - pathology</topic><topic>Transcriptome</topic><topic>Transformations</topic><topic>Translocation</topic><topic>Tumor suppressor genes</topic><topic>Tumors</topic><topic>Ubiquitin-Protein Ligases - genetics</topic><topic>Ubiquitin-Protein Ligases - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mets, E</creatorcontrib><creatorcontrib>Van der Meulen, J</creatorcontrib><creatorcontrib>Van Peer, G</creatorcontrib><creatorcontrib>Boice, M</creatorcontrib><creatorcontrib>Mestdagh, P</creatorcontrib><creatorcontrib>Van de Walle, I</creatorcontrib><creatorcontrib>Lammens, T</creatorcontrib><creatorcontrib>Goossens, S</creatorcontrib><creatorcontrib>De Moerloose, B</creatorcontrib><creatorcontrib>Benoit, Y</creatorcontrib><creatorcontrib>Van Roy, N</creatorcontrib><creatorcontrib>Clappier, E</creatorcontrib><creatorcontrib>Poppe, B</creatorcontrib><creatorcontrib>Vandesompele, J</creatorcontrib><creatorcontrib>Wendel, H-G</creatorcontrib><creatorcontrib>Taghon, T</creatorcontrib><creatorcontrib>Rondou, P</creatorcontrib><creatorcontrib>Soulier, J</creatorcontrib><creatorcontrib>Van Vlierberghe, P</creatorcontrib><creatorcontrib>Speleman, F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Leukemia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mets, E</au><au>Van der Meulen, J</au><au>Van Peer, G</au><au>Boice, M</au><au>Mestdagh, P</au><au>Van de Walle, I</au><au>Lammens, T</au><au>Goossens, S</au><au>De Moerloose, B</au><au>Benoit, Y</au><au>Van Roy, N</au><au>Clappier, E</au><au>Poppe, B</au><au>Vandesompele, J</au><au>Wendel, H-G</au><au>Taghon, T</au><au>Rondou, P</au><au>Soulier, J</au><au>Van Vlierberghe, P</au><au>Speleman, F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia</atitle><jtitle>Leukemia</jtitle><addtitle>Leukemia</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>29</volume><issue>4</issue><spage>798</spage><epage>806</epage><pages>798-806</pages><issn>0887-6924</issn><eissn>1476-5551</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><notes>These two authors shared co-authorship.</notes><abstract>The MYB oncogene is a leucine zipper transcription factor essential for normal and malignant hematopoiesis. In T-cell acute lymphoblastic leukemia (T-ALL), elevated MYB levels can arise directly through T-cell receptor-mediated MYB translocations, genomic MYB duplications or enhanced TAL1 complex binding at the MYB locus or indirectly through the TAL1/miR-223/FBXW7 regulatory axis. In this study, we used an unbiased MYB 3'untranslated region-microRNA (miRNA) library screen and identified 33 putative MYB-targeting miRNAs. Subsequently, transcriptome data from two independent T-ALL cohorts and different subsets of normal T-cells were used to select miRNAs with relevance in the context of normal and malignant T-cell transformation. Hereby, miR-193b-3p was identified as a novel bona fide tumor-suppressor miRNA that targets MYB during malignant T-cell transformation thereby offering an entry point for efficient MYB targeting-oriented therapies for human T-ALL.</abstract><cop>England</cop><pub>Nature Publishing Group</pub><pmid>25231743</pmid><doi>10.1038/leu.2014.276</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0887-6924
ispartof Leukemia, 2015-04, Vol.29 (4), p.798-806
issn 0887-6924
1476-5551
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4890642
source Springer Link
subjects 3' Untranslated Regions
Acute lymphoblastic leukemia
Acute lymphocytic leukemia
Animals
Basic Helix-Loop-Helix Transcription Factors - genetics
Basic Helix-Loop-Helix Transcription Factors - metabolism
Care and treatment
Cdc4 protein
Cell Cycle Proteins - genetics
Cell Cycle Proteins - metabolism
Cell Transformation, Neoplastic - genetics
Cell Transformation, Neoplastic - metabolism
Development and progression
F-Box Proteins - genetics
F-Box Proteins - metabolism
F-Box-WD Repeat-Containing Protein 7
Gene expression
Gene Expression Profiling
Gene Expression Regulation, Leukemic
Genetic aspects
Genomic Library
Health aspects
Hematopoiesis
Humans
Innovations
Leucine
Leucine zipper proteins
Leukemia
Lymphatic leukemia
Lymphocytes T
Mice
MicroRNA
MicroRNAs
MicroRNAs - genetics
MicroRNAs - metabolism
miRNA
Molecular targeted therapy
Oncogenes
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology
Primary Cell Culture
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins - metabolism
Proto-Oncogene Proteins c-myb - genetics
Proto-Oncogene Proteins c-myb - metabolism
Ribonucleic acid
RNA
Signal Transduction
T cell receptors
T-Cell Acute Lymphocytic Leukemia Protein 1
T-Lymphocytes - metabolism
T-Lymphocytes - pathology
Transcriptome
Transformations
Translocation
Tumor suppressor genes
Tumors
Ubiquitin-Protein Ligases - genetics
Ubiquitin-Protein Ligases - metabolism
title MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T04%3A43%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MicroRNA-193b-3p%20acts%20as%20a%20tumor%20suppressor%20by%20targeting%20the%20MYB%20oncogene%20in%20T-cell%20acute%20lymphoblastic%20leukemia&rft.jtitle=Leukemia&rft.au=Mets,%20E&rft.date=2015-04-01&rft.volume=29&rft.issue=4&rft.spage=798&rft.epage=806&rft.pages=798-806&rft.issn=0887-6924&rft.eissn=1476-5551&rft_id=info:doi/10.1038/leu.2014.276&rft_dat=%3Cgale_pubme%3EA410904298%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c602t-c6717f4c95c5852059085f7362b49383b98a52ea73b7faf6d4cb5bedf8e40af33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1672072777&rft_id=info:pmid/25231743&rft_galeid=A410904298&rfr_iscdi=true